CEACAM5 and breast carcinoma: Carcinoembryonic antigen (CEA) is mainly used for clinical monitoring of colorectal cancer, gastric cancer, breast cancer, pancreatic cancer, hepatocellular carcinoma, lung cancer, and medullary thyroid cancer, which is of great value in the diagnosis, screening, and prognosis of tumors [15].